Avadel Pharmaceuticals (AVDL) Shares Outstanding (2016 - 2022)
Historic Shares Outstanding for Avadel Pharmaceuticals (AVDL) over the last 13 years, with Q3 2022 value amounting to $60.9 million.
- Avadel Pharmaceuticals' Shares Outstanding rose 387.1% to $60.9 million in Q3 2022 from the same period last year, while for Sep 2022 it was $60.9 million, marking a year-over-year increase of 387.1%. This contributed to the annual value of $58.6 million for FY2021, which is 38.36% up from last year.
- According to the latest figures from Q3 2022, Avadel Pharmaceuticals' Shares Outstanding is $60.9 million, which was up 387.1% from $59.0 million recorded in Q2 2022.
- In the past 5 years, Avadel Pharmaceuticals' Shares Outstanding registered a high of $63.5 million during Q2 2020, and its lowest value of $42.1 million during Q1 2018.
- In the last 5 years, Avadel Pharmaceuticals' Shares Outstanding had a median value of $58.2 million in 2020 and averaged $51.9 million.
- As far as peak fluctuations go, Avadel Pharmaceuticals' Shares Outstanding surged by 4857.94% in 2020, and later tumbled by 794.66% in 2021.
- Avadel Pharmaceuticals' Shares Outstanding (Quarter) stood at $42.7 million in 2018, then grew by 0.48% to $42.9 million in 2019, then skyrocketed by 36.04% to $58.4 million in 2020, then increased by 0.38% to $58.6 million in 2021, then grew by 3.86% to $60.9 million in 2022.
- Its Shares Outstanding was $60.9 million in Q3 2022, compared to $59.0 million in Q2 2022 and $59.0 million in Q1 2022.